A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patients.
about
Dose Reduction of Caspofungin in Intensive Care Unit Patients with Child Pugh B Will Result in Suboptimal Exposure.Does Weight Impact Anidulafungin Pharmacokinetics?Pharmacokinetics of Anidulafungin in Critically Ill Intensive Care Unit Patients with Suspected or Proven Invasive Fungal InfectionsPharmacokinetics of antifungal drugs: practical implications for optimized treatment of patients.
P2860
A rationale for reduced-frequency dosing of anidulafungin for antifungal prophylaxis in immunocompromised patients.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
A rationale for reduced-freque ...... in immunocompromised patients.
@en
type
label
A rationale for reduced-freque ...... in immunocompromised patients.
@en
prefLabel
A rationale for reduced-freque ...... in immunocompromised patients.
@en
P2093
P2860
P356
P1476
A rationale for reduced-freque ...... in immunocompromised patients
@en
P2093
C A J Knibbe
D M Burger
N M A Blijlevens
R J M Brüggemann
W J F M Van Der Velden
P2860
P304
P356
10.1093/JAC/DKU477
P407
P577
2014-12-03T00:00:00Z